University of Manchester

Perhaps bolstering the already strong commercial presence for its IL-23 inhibitor and Humira successor Skyrizi, AbbVie Inc. unveiled data during the American Academy of Dermatology meeting that took

Vor Hopes NCI’s CAR-T Candidate Is Synergistic With Lead AML Therapy PureTech Health plc -backed Vor Biopharma Inc. said on 11 November that it has licensed a clinical-stage chimeric antigen recept

Below is Scrip ’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Unite

Below is Scrip’s monthly roundup, including information from Strategic Transactions , of recent technology transfer agreements between companies and academic or other research institutions. Deerfiel